Ramaprasad Srinivasan, M.D., Ph.D.

Ramaprasad  Srinivasan, M.D., Ph.D.
Investigator
Head, Molecular Cancer Therapeutics Section

Dr. Srinivasan is developing treatment strategies and clinical trials for patients with both hereditary and non-hereditary forms of kidney cancer. Currently, he is investigating a variety of newer 'targeted' agents in clear cell and papillary kidney cancer, as well as hereditary kidney cancer syndromes such as von Hippel-Lindau, hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary papillary renal cell cancer (HPRC).

Areas of Expertise

1) kidney cancer

Contact Info

Ramaprasad Srinivasan, M.D., Ph.D.
Center for Cancer Research
National Cancer Institute
Building 10 - Hatfield CRC, Room 1-5940
Bethesda, MD 20892
Ph: 240-858-3700
Fax: 301-480-2869
ramasrin@mail.nih.gov

Selected Recent Publications

  1. Ball MW, An JY, Gomella PT, Gautam R, Ricketts CJ, Vocke CD, Schmidt LS, Merino MJ, Srinivasan R, Malayeri AA, Metwalli AR, Linehan WM.
    J Clin Oncol. 38(11): 1146-1153, 2020. [ Journal Article ]
  2. Kauffman EC, Lang M, Rais-Bahrami S, Gupta GN, Wei D, Yang Y, Sourbier C, Srinivasan R.
    BMC Cancer. 19(1): 917, 2019. [ Journal Article ]
  3. Linehan WM, Schmidt LS, Crooks DR, Wei D, Srinivasan R, Lang M, Ricketts CJ.
    Cancer Discov. 9(8): 1006-1021, 2019. [ Journal Article ]
  4. Ball MW, Srinivasan R.
    Nat Rev Urol. 15(2): 77-78, 2018. [ Journal Article ]
  5. Ball MW, Singer EA, Srinivasan R.
    Curr Opin Oncol. 1: 10, 2017. [ Journal Article ]

Ramaprasad Srinivasan obtained his M.D. from the Bangalore Medical College in India and then completed his Ph.D. in biomedical sciences at the University of Texas MD Anderson Cancer Center in Houston. He came to the NCI in 1999 after completing his internal medicine residency training at the University of Texas Health Science Center-Houston, to pursue a fellowship in medical oncology/hematology. After completing his fellowship, Dr. Srinivasan joined the Urologic Oncology Branch as a Staff Clinician. In 2016 he became a Principal Investigator. Dr. Srinivasan is developing treatment strategies and clinical trials for patients with both hereditary and non-hereditary forms of kidney cancer. Currently, he is investigating a variety of newer 'targeted' agents in clear cell and papillary kidney cancer, as well as hereditary kidney cancer syndromes such as von Hippel-Lindau, hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary papillary renal cell cancer (HPRC).

Name Position
Munjid Al Harthy, M.D. Assistant Research Physician
Donna Drake Data Manager (Contr.)
Julia Friend P.A. Physician Assistant
Janet Gichonge Patient Care Coordinator (Contr)
Sameer Issaq Ph.D. Biologist
Paul Leger M.D. Clinical Fellow
Lisa Mac P.A. Physician Assistant (Contr.)
Roma Pahwa Ph.D. Postdoctoral Fellow (Visiting)
Erin Purcell R.N. Research Nurse